勘误：在透明细胞肾细胞癌患者中，CDC6表达增加与预后不良相关。
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
作者信息
Yao Yicong, Wang Yi, Wu Denglong, Hu Baoying
机构信息
Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
School of Medicine, Tongji University, Shanghai, China.
出版信息
Front Oncol. 2021 Jul 21;11:731942. doi: 10.3389/fonc.2021.731942. eCollection 2021.
Abstract
[This corrects the article DOI: 10.3389/fonc.2021.666418.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fonc.2021.666418。]
相似文献
1
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Front Oncol. 2021 Jul 21;11:731942. doi: 10.3389/fonc.2021.731942. eCollection 2021.
2
Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Front Oncol. 2021 May 24;11:666418. doi: 10.3389/fonc.2021.666418. eCollection 2021.
3
Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Front Oncol. 2021 Oct 5;11:730782. doi: 10.3389/fonc.2021.730782. eCollection 2021.
4
Corrigendum: STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival Inhibiting Cell Growth and Invasion.
Front Oncol. 2021 Sep 8;11:726290. doi: 10.3389/fonc.2021.726290. eCollection 2021.
5
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
Front Oncol. 2022 Aug 22;12:979968. doi: 10.3389/fonc.2022.979968. eCollection 2022.
6
Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.
7
Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
Front Oncol. 2023 Mar 21;13:1134139. doi: 10.3389/fonc.2023.1134139. eCollection 2023.
8
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma.
Front Cell Dev Biol. 2023 Jun 1;11:1216783. doi: 10.3389/fcell.2023.1216783. eCollection 2023.
9
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma.
Front Cell Dev Biol. 2024 Apr 3;12:1396267. doi: 10.3389/fcell.2024.1396267. eCollection 2024.
10
Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma.
Front Oncol. 2023 Aug 23;13:1247057. doi: 10.3389/fonc.2023.1247057. eCollection 2023.
Zotero 插件